RESUMO
The aim of the article was to discuss haemodynamics and septic shock for COVID-19. Recommendations for the management of acute kidney injury and liver dysfunctionManagement of acute kidney injury associated with COVID-19. The etiology of acute kidney injury (AKI) associated with COVID-19 is multifactorial, involving factors specific to the disease itself (viral tropism, proinflammatory cytokines, coagulopathy with thrombotic microangiopathy, rhabdomyolysis), and nonspecific, linked to the treatment of critically ill patients. The diagnosis of AKI is made using the diagnostic criteria of the KDIGO definition, through frequent monitoring of creatinine and urinary output in order to carry out early detection of renal involvement. There are no specific measures for prevention and treatment of acute kidney injury associated with CO-VID-19, but immunomodulatory treatment (corticosteroids) and coagulopathy (heparin) could contribute to reducing its incidence and magnitude. Some of the measures to treat the non-specific factors involved in the development of acute kidney injury are also discussed in this study.